Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

Trial Overview

Am I Eligible?

Participating US Centers

Dana-Farber Cancer Institute

This center is currently accepting patients.

Boston, MA


This trial is currently open and accepting patients.

Additional Information
Trial Phase

Observational Trial

Trial Enrollment

50000 sparks required

Trial Sponsors
  • Dana-Farber Cancer Institute
Trial Collaborators
  • Stand Up To Cancer
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST